Kazia Therapeutics Limited (KZIA) Earnings Call Transcripts

10 earnings calls from June 2020 to September 1, 2026

NasdaqCM US Health Care Biotechnology

About Kazia Therapeutics Limited

Kazia Therapeutics Limited (KZIA) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 10 calls on record spanning June 26, 2020 to September 1, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 10 Kazia Therapeutics Limited earnings call transcripts on record, spanning June 26, 2020 to September 1, 2026. Based on this history, Kazia Therapeutics Limited reports annually. The most recent call on file is dated September 1, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
KZIA
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
10
First call
June 26, 2020
Most recent
September 1, 2026
Reporting cadence
annually
Quarter Date
Special Calls Sep 1, 2026 Read transcript
Shareholder/Analyst Calls May 22, 2025 Read transcript
Shareholder/Analyst Calls Nov 29, 2023 Read transcript
Shareholder/Analyst Calls Nov 15, 2022 Read transcript
Special Calls Jun 22, 2022 Read transcript
Special Calls May 13, 2022 Read transcript
Special Calls May 13, 2022 Read transcript
Special Calls Nov 4, 2021 Read transcript
Special Calls Nov 19, 2020 Read transcript
Company Conference Presentations Jun 26, 2020 Read transcript